Previous results have indicated that mitochondrial ATP-sensitive potassium (mitoK ATP ) channels are associated with the hypoxic proliferation of pulmonary artery smooth muscle cells (PASMCs). However, the mechanism underlying the promotive effects of mitoK ATP channels on cell proliferation in response to hypoxia remains unknown. mitoK ATP channel opening results in a collapse of mitochondrial membrane potential and generation of mitochondrial reactive oxygen species (ROS). As hypoxia-inducible factor-1α (HIF-1α) is a critical oxygen sensor and major transcriptional regulator of the hypoxic adaptive response, the current study assessed whether mitoK ATP opening contributes to the chronic proliferation of human PASMCs (hPASMCs) in collaboration with HIF-1α and its downstream targets under hypoxic conditions. The present study demonstrated that there was crosstalk between mitoK ATP channels and HIF-1α signaling in PASMCs under hypoxic conditions. The results suggest that mitoK ATP channels are involved in the proliferation of PASMCs during hypoxia through upregulation of the ROS/HIF/microRNA-210/iron-sulfur cluster protein signaling pathway.
Introduction
Pulmonary arterial hypertension (PAH) is a life-threatening disorder characterized by obstructive remodeling of the pulmonary arteries, which may lead to right-sided heart failure and mortality (1) (2) . PAH may be defined as a mean pulmonary artery pressure (mPAP) of ≥20 mmHg at rest or >30 mmHg with exercise, along with a pulmonary artery occlusion pressure of ≤15 mmHg (1-2). The estimated incidence of primary pulmonary hypertension is 1-2/million in the global population (1-2). There are currently three treatment pathways, namely phosphodiesterase type 5 inhibitor or soluble guanylate cyclase stimulator, prostacyclin class therapy and endothelium receptor antagonist, which target the imbalances of three substances; nitric oxide, prostacyclin and endothelin, respectively (3) . Despite the efficacy of these pharmacological therapies in improving symptoms, they do not prevent the progression of PAH or reduce the mortality rate of patients (3) . Therefore, novel approaches that more effectively target PAH are required to control the cellular components associated with pulmonary remodeling. The chronic and continued proliferation of human pulmonary artery smooth muscle cells (hPASMCs), in addition to apoptotic resistance, leads to hypoxic pulmonary arterial remodeling, which is considered to be a key mechanism for the pathological development of PAH (4) . ATP-sensitive potassium (K ATP ) channels are located on the cytoplasmic membrane and on subcellular membranes. Subcellular membrane-associated K ATP channels are divided into three types: Sarcolemmal K ATP , mitochondrial K ATP (mitoK ATP ) and nuclear K ATP . MitoK ATP channels, which contribute to the control of mitochondrial volume and energetic status (5-7), exhibit high sensitivity to hypoxia (8 Key words: mitochondrial ATP-sensitive potassium channel, pulmonary artery smooth muscle cells, hypoxia, hypoxia-inducible factor-1α, microRNA-210, iron-sulfur cluster protein, mitochondrial membrane potential and depolarization of the mitochondrial membrane potential (ΔΨm) is induced accordingly (9) . In addition, previous studies indicate that the opening of mitoK ATP channels leads to the generation of reactive oxygen species (ROS) (5-7). ROS are considered to be a double-edged sword, and their effect on cells as either a survival or apoptotic signal is controlled by the dosage, duration, type and site of ROS production (5-7). Furthermore, opening of mitoK ATP channels followed by ΔΨm depolarization may contribute to increased expression of hypoxia-inducible factor-1α (HIF-1α) and proliferation of PASMCs (10) . A previous study demonstrated that mitoK ATP channel opening participates in ROS overproduction in hPASMCs through ΔΨm depolarization, which indicates the involvement of mitoK ATP in the chronic proliferation and/or enhanced apoptotic resistance of hPASMCs (11) . However, the molecular mechanism underlying the role of mitoK ATP channels in the abnormal proliferation or apoptotic resistance of hPASMCs remains unknown.
The present study investigated whether mitoK ATP channels promote the aberrant prolonged proliferation of hPASMCs by assessing ΔΨm and intracellular ROS. The results indicated that mitoK ATP channels contribute to hypoxic pulmonary arterial remodeling via regulation of the ROS/HIF/microRNA (miR)-210/iron-sulfur cluster protein (ISCU) signaling pathway.
Materials and methods
Cell culture and treatment. hPASMCs were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in smooth muscle cell medium (ScienCell Research Laboratories, Inc.) supplemented with 2% fetal bovine serum (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), 100 U/ml penicillin, 100 µg/ml streptomycin and 1% smooth muscle cell growth supplement (all ScienCell Research Laboratories) in an atmosphere containing 5% CO 2 at 37˚C. The culture medium was replaced every 2 to 3 days until cell 80% confluence was reached. hPASMCs at passages 4-10 were used in the following experimental assays. Smooth muscle cells were confirmed by immunohistochemistry using anti-α-actin monoclonal antibody (dilution 1:300; sc-130616; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) incubated at 37˚C for 2 h. The cells were cultured at 37˚C in hypoxic conditions (5% CO 2 and 5% O 2 ) or normoxic conditions (1% CO 2 and 20% O 2 ) as control for 6, 12 and 24 h respectively, prior to the experiment. Subsequently, after treatment with mitoK ATP inhibitor 5-hydroxydecanoate (5-HD; 500 µmol/l), mitoK ATP agonist diazoxide (100 µmol/l) or HIF-1α inhibitor 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1; 50 µmol/l; all from Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) or smooth muscle cell medium supplemented with 2% fetal bovine serum as control for 1 h, immediately the cells were further maintained at 37˚C in a humidified atmosphere of 5% CO 2 and 5% O 2 for 6,12 and 24 h.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR). mRNA and miRNA PCR experiments were performed in triplicate. For mRNA expression assay, total RNA was extracted from treated cells using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). cDNA was synthesized using a ReverTra Ace qPCR RT kit (Toyobo Co., Ltd., Osaka, Japan). RNA concentration and purity were assessed by UV spectrophotometry (1.8<A260/A280<2.0). RNA integrity was assessed using electrophoresis. Reverse transcription reaction was performed using 4 µg of total RNA and the First Strand cDNA Synthesis kit (Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. To generate standard curves, 1 µl of first-strand cDNA was amplified using a Premix Ex Taq Version Kit (Takara Bio, Inc., Otsu, Japan) according to the manufacturer's instructions and quantification of PCR products was assessed to plot standard curves. The qPCR reactions were performed using a SYBR Green PCR Master mix (CWBIO; Beijing, China) in a CFX-96 system (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using the following primers: HIF-1α, forward 5'-CTG ATC ATC TGA CCA AAA CTC-3' and reverse 5'-GTT TCA ACC CAG ACA TAT CCA C-3'; and β-actin, forward 5'-ACT CTT CCA GCC TTC CTT CC-3' and reverse 5'-CGT CAT ACT CCT GCT TGC TG-3'. Real-time PCR was performed using the SYBR Premix Ex TaqTM II (Takara Bio, Inc.) protocol on a Bio-Rad Connect real-time PCR detection system with cycling conditions of 95˚C for 3 min, followed by 40 cycles of 95˚C for 30 sec and 60˚C for 30 sec. β-actin was used as an internal control. The relative mRNA expression levels were determined using the 2 -ΔΔCq method and normalized to β-actin mRNA (12, 13) . For the miR-210 expression assay, total cellular RNA was extracted with TRIzol reagent. cDNA was synthesized by reverse transcription using the miRNART-primer (RibBio Co., Ltd., Guangzhou, China). The qPCR reactions were performed using a SYBR Green PCR Master mix using miR-210 and U6 primer purchased from RibBio Co., Ltd. (sequences not supplied), which served as normalization control. qPCR was performed under the following steps: 95˚C for 3 min, followed by 40 cycles of 95˚C for 30 sec and 56˚C for 30 sec. miR-210 expression relative to U6 control was calculated using the 2 -ΔΔCq method (14) .
Measurement of ΔΨm and intracellular ROS.
The ΔΨm was monitored using flow cytometry according to a modified method (15) . Briefly, treated cells were detached by trypsinization and washed twice in PBS. A total of 10 µg/ml rhodamine-123 (R-123, Sigma-Aldrich; Merck KGaA) was then added and incubated for 30 min at 37˚C in the dark. The fluorescence intensity of cells was measured using a FACSAria II cytometer (BD643182; BD Biosciences, San Jose, CA, USA). Measurement of mitochondrial intracellular ROS was performed as described previously (11) . The fluorescent probe 2',7'-dichlorofluorescin diacetate (DCFH-DA) was purchased from Sigma-Aldrich; Merck KGaA.
RNA transfection. A total of 2x10
5 cells were plated into 6-well plates ins mooth muscle cell medium supplemented with 2% fetal bovine serum in normoxic conditions (1% CO 2 and 20% O 2 ) at 37˚C for 24 h. Cells were transfected with miR-210 mimic (miR-210) or inhibitor (anti-210) (RibBio Co., Ltd.) at a final concentration of 80 nmol/l, or three small interfering RNAs (siRNA1, siRNA2 and siRNA3) against ISCU (GenePharma, Shanghai, China) at a final concentration of 5 nmol/l using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) with serum-free smooth muscle cell medium, as described previously (11) . The follow sequences were used: miR-210 mimic, forward 5'-CUG UGC GUG UGA CAG CGG GUG A-3' and reverse 5'-UUG ACA CGC ACA CUG UCG CCG A-3'; and inhibitor, forward 5'-UCA GCC GCU GUC ACA CGC ACA G-3' and reverse 5'-CAG UAC UUU UGU GUA GUA CAA-3'. After 6 h, the culture medium was replenished with fresh smooth muscle cell medium supplemented 2% fetal bovine serum and cells were cultured for an additional 24 h at 37˚C, then subjected to hypoxia (5% CO 2 and 5% O 2 ) and normoxia (1% CO 2 and 20% O 2 ) at 37˚C for 24 h. Control miR sequences and control siRNA sequences were used (miR-con, anti-con, si-con) as negative control. After miR-210 inhibitor and control transfection for 24 h, cells were treated with 5-HD (500 µmol/l) or diazoxide (100 µmol/l) and exposed to hypoxia for 48 h at 37˚C.
Western blot analysis. Cells were lysed with lysis buffer (1% Triton X-100, 50 mmol/l Tris-HCl, pH 7.4, 25 mmol/l glycerophosphate, 150 mmol/l NaCl, 2 mmol/l EDTA, 2 mmol/l ethylene glycol tetraacetic acid, 1 mmol/l phenylmethylsulfonyl fluoride, 10% glycerol and 1% protease and phosphatase inhibitors) for 10 min on ice. The lysates were collected and centrifuged at 15,000 x g for 15 min at 4˚C. The supernatant was recovered, and protein concentration was measured using a protein assay kit (Pierce; Thermo Fisher Scientific, Inc.). The proteins loaded (40 mg per lane) were subsequently separated by 12% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (PVDF; Thermo Fisher Scientific, Inc.), blocked at 37˚C for 2 h in 5% non-fat milk, and incubated with anti-proliferating cell nuclear antigen (PCNA; sc-25280) or anti-ISCU antibody (sc-271536) or β-actin antibody (sc-47778) or GAPDH (sc-25778) at 1:4,000 or 1:3,000 or 1:10,000 or 1:5,000, respectively (Santa Cruz Biotechnology, Inc.) at 4˚C overnight. After washing for 10 min in 1X Tris-buffered saline-Tween-20 solution three times, the target protein was probed with the horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (sc-3841; at 1:6,000 dilution; Santa Cruz Biotechnology, Inc.) at 37˚C for 2 h. After washing for 10 min in 1X Tris-buffered saline-Tween-20 solution three times, the bound antibody on the PVDF membrane was detected by chemiluminescence with the ECL Detection Reagent kit (Pierce; Thermo Fisher Scientific, Inc.) and the protein expression was analyzed using Quantity One 4.6.2 (Bio-Rad Laboratories, Inc.) (16) .
Statistical analysis. Statistical analysis was performed using one-way analysis of variance and Duncan's test using Graphpad software (version 5.0; GraphPad Software, Inc., La Jolla, CA, USA). The data were expressed as the mean ± standard deviation in three independent experiments. The statistical significance of differences among groups was determined using an analysis of variance or Student's t-test. P<0.05 was considered to represent a statistically significant difference.
Results
MitoK ATP increases ROS generation in hPASMCs through the collapse of ΔΨm. Hypoxia-triggered mitoK ATP channel opening initiated by ATP depletion leads to the collapse of ΔΨm, which has been implicated in the generation of ROS (17) . Consistent with a previous report (11) , the present study observed that R-123 fluorescence intensity was significantly increased in hPASMCs subjected to hypoxia for 12 and 24 h (P<0.05 and P<0.01, respectively), relative to normoxic control cells (Fig. 1A) , indicating that ΔΨm depolarization had occurred. Furthermore, hPASMCs exhibited significantly increased levels of ROS after 12 and 24 h of hypoxia (P<0.05), as determined by DCFH-DA staining (Fig. 1B) . To further investigate whether mitoK ATP channels were associated with ROS production in hPASMCs, the levels of intracellular ROS were measured following treatment with diazoxide or 5-HD, to activate or inhibit mitoK ATP , respectively. As predicted, opening of mitoK ATP significantly increased the level of intracellular ROS, and closure of mito-K ATP significantly decreased the level of intracellular ROS under hypoxic conditions (P<0.05; Fig. 1C ). Furthermore, under normoxic conditions, the opening of mitoK ATP significantly increased the level of intracellular ROS while closure of mitoK ATP significantly decreased the level of intracellular ROS (P<0.05; Fig. 1C ). These results suggest that mitoK ATP channels may be involved in the generation of ROS in hPASMCs under hypoxic conditions, potentially through the collapse of ΔΨm. 
MitoK ATP interacts with HIF-1α in a positive feedback manner in hPASMCs.
As HIF-1α is a critical oxygen sensor and master transcriptional regulator of the hypoxic adaptive response, it has been suggested that mitoK ATP channels function in combination with HIF-1α and its downstream targets, including miR-210 and ISCU (12, 18) . To investigate whether mitoK ATP was associated with the expression of HIF-1α and miR-210 in hPASMCs during hypoxia, the expression of HIF-1α mRNA and miR-210 was measured using RT-qPCR. In hPASMCs subjected to hypoxia, levels of HIF-1α mRNA were significantly increased at 12 and 24 h (P<0.01 and P<0.001, respectively), and miR-210 levels were significantly increased at 6 and 12 h (P<0.05; Fig. 2A ). In turn, expression of miR-210 was significantly decreased following treatment with the HIF-1α inhibitor YC-1 (P<0.01; Fig. 2B ), and expression of HIF-1α was significantly increased following treatment with the mitoK ATP agonist diazoxide (P<0.05; Fig. 2C) . Furthermore, the levels of HIF-1α mRNA and miR-210 were significantly decreased following closure of mitoK ATP with 5-HD (P<0.001 and P<0.01, respectively; Fig. 2C ). To further investigate whether HIF-1α was involved in the regulation of mitoK ATP , ΔΨm and ROS levels were measured in hPASMCs treated with YC-1. Significant decreases in the fluorescence intensity of R-123 (P<0.05) and DCFH-DA (P<0.01) were observed in hPASMCs upon inhibition of HIF-1α (Fig. 2D) .
These data suggest that mitoK ATP channel opening increases the expression of HIF-1α and its downstream target miR-210, leading to HIF-1α-mediated regulation of mitoK ATP through increased ROS levels in a positive feedback manner in hPASMCs under hypoxic conditions. -210 (19,20) . ISCU, as an essential component of respiratory electron transfer complexes, is involved in ROS generation in the mitochondria (21) . The present study blocked the expression of miR-210 using an inhibitor of miR-210. Under normoxic and hypoxic conditions, significant decreases in the fluorescence intensity of R-123 (P<0.001 and P<0.01, respectively) and DCFH-DA (P<0.01) were observed in hPASMCs upon treatment with miR-210 inhibitor transfection (Fig. 3A and B) , indicating an involvement of miR-210 in the alteration of ΔΨm and generation of ROS. The expression of ISCU was subsequently assessed, and was demonstrated to be reduced or increased following treatment with miR-210 mimic or miR-210 inhibitor under normoxic conditions, respectively (Fig. 3C) . As shown in Fig. 3C , ISCU expression was reduced under hypoxic conditions compared with normoxic conditions. Furthermore, in order to determine the role of ISCU in the activity of mitoK ATP , specific siRNA against ISCU or scrambled control siRNA was transfected into hPASMCs. Western blot analysis indicated that two of the three siRNAs specifically reduced the expression of ISCU (Fig. 3D) . In addition, a significant increase in the fluorescence intensity of R-123 was observed in hPASMCs upon treatment with ISCU siRNA (P<0.01; Fig. 3E ), which suggests a role of ISCU in the collapse of ΔΨm, the fluorescence intensity of R-123 was lower in hypoxic environments. Loss of ISCU may impair the function of the electron transfer chain, leading to increased generation of ROS and decreased production of ATP. Decreased levels of ATP may then trigger opening of mitoK ATP channels and a collapse of ΔΨm. These data suggest that mitoK ATP channels indirectly participate in ROS generation in hPASMCs under hypoxic conditions via the miR-210/ISCU pathway. This may supplement the potential direct involvement of mitoK ATP in ROS generation, mediated by channel opening and ΔΨm collapse.
MitoK ATP participates in ROS generation in hPASMCs under hypoxic conditions through miR-210/ISCU. Previous studies have indicated that ISCU is a downstream regulatory target of miR
MitoK ATP promotes the proliferation of hPASMCs through miR-210 signaling. As hPASMCs grow relatively slowly, the proliferation of hPASMCs was evaluated by measuring the expression of PCNA, as an established marker of cell proliferation that is synthesized in the early G1 and S phases of the cell cycle (22) . Results of western blot analysis showed that PCNA expression was markedly increased in hPASMCs subjected to hypoxia for 48 h, relative to normoxic controls (Fig. 4A) . The proliferation of hPASMCs upon activation or inhibition of mitoK ATP and inhibition of miR-210 was subsequently assessed. It was observed that activation of mitoK ATP increased the expression of PCNA, while inhibition of mitoK ATP and miR-210 decreased PCNA expression (Fig. 4B) . These results indicate that mitoK ATP promotes the proliferation of hPASMCs under hypoxic conditions through the miR-210 signaling pathway.
Discussion
The proliferation and survival of hPASMCs are essential in hypoxic pulmonary arterial remodeling, which typically leads to PAH (4). K ATP channels were initially identified in the inner membrane of liver mitochondria (23) . Previous results suggest that the opening of mitoK ATP channels, which induces the collapse of ΔΨm, contributes to the proliferation and survival of different cell types, including cardiac myocytes (24) , renal epithelial cells (25) , cerebellar granule neurons (26) and skin cells (27) . A previous study also demonstrated that hypoxic proliferation of hPASMCs was associated with mitoK ATP channel opening (11) . However, the molecular mechanism underlying the promotive effect of mitoK ATP channel opening on hPASMC proliferation in PAH remains unclear.
ROS has been implicated as a trigger that causes aberrant proliferation or apoptotic resistance in hPASMCs under hypoxic conditions (28) . It has been reported that a collapse of ΔΨm, resulting from mitoK ATP channel opening, leads to mitochondrial respiratory chain disorders associated with an increase in complex III-dependent ROS and a decrease in complex I-dependent ROS (21) . Thus, complex III is considered to be a major ROS-releasing site during phases of decreased membrane potential mediated by mitoK ATP channel opening (28) .
However, it is established that HIF-1α is a critical regulator of the hypoxic adaptive response during hypoxia stress (22, 23) . Under normoxic conditions, HIF-1α is hydroxylated by HIF prolyl-hydroxylases, which enables its recognition and ubiquitination by von Hippel-Lindau E3 ubiquitin ligase, with ubiquitin serving as a signal for proteosomal degradation (24, 25) . As HIF prolyl-hydroxylase utilizes oxygen as a co-substrate, it is inhibited in response to hypoxia, which allows HIF-1α to function. This negative regulation mediated by HIF prolyl-hydroxylase is an additional mechanism of HIF-1α regulation linked to ROS (11, 28) . Increases in mitochondrial ROS induced by hypoxia has been demonstrated to contribute to HIF-1α stabilization under hypoxic conditions (29) (30) (31) . As HIF-1α is a major transcriptional regulator of the cellular and developmental response to hypoxia (32, 33) , it is possible that crosstalk occurs between HIF-1α and mitoK ATP during hPASMC proliferation under hypoxic conditions. In accordance with this assumption, the present data indicated that mitoK ATP channel opening participates in the chronic proliferation of hPASMCs in collaboration with HIF-1α under hypoxic conditions. miR-210, which is upregulated by HIF-1α, is considered to be among the most hypoxia-sensitive miRs and a microregulator of the hypoxia pathway (34) . As a downstream target of miR-210 (12, 33, 35) , ISCU is responsible for the assembly of iron sulfur clusters [Fe-S] in mitochondrial respiratory complexes (complexes I, II and III) (21, 36) . Dysfunction of ISCU leads to an impaired electron transport chain, which results in two consequences: i) ROS generation or ii) a decreased H + gradient leading to suppressed production of ATP. Subsequently, mito-K ATP channels are opened in response to reduced levels of ATP (11, 28) . Previous data suggest that HIF-1/miR-210/ISCU may act as a critical signaling axis in the regulation of mitochondrial metabolism during hypoxia (19, (36) (37) (38) . Consistent with these findings, results of the present study suggested that mitoK ATP promotes the proliferation of hPASMCs via upregulation of the ROS/HIF/miR-210/ISCU signaling pathway.
The present study demonstrated that mitoK ATP channels were involved in the proliferation of hPASMCs under hypoxic conditions. An increase in ROS during hypoxia leads to a downregulation in HIF prolyl-hydroxylase, enabling it to function as a regulator of the hypoxic response. Due to dysfunction of respiratory chain complexes in the inner mitochondrial membrane, ROS levels may be generated by two positive feedback loops: ROS/HIF/miR-210/ISCU and ATP/mitoK ATP/ ΔΨm. Aberrancies in the levels of ROS ultimately lead to the proliferation of hPASMCs under hypoxic conditions. The potential association between mitoK ATP and the chronic proliferation of hPASMCs suggests that targeting of mitoK ATP may be a useful strategy for the treatment of hypoxia-associated pulmonary diseases, including PAH.
In conclusion, HIF-1α functions in the hypoxia adaptive response following reduced inhibition by prolyl-hydroxylase, and serves its role due to increased generation of ROS. Elevated levels of ROS, which have been associated with dysfunction of respiratory chain complexes, may be further upregulated by two positive feedback loops: ROS/HIF/miR-210/ISCU and ATP/mitoK ATP/ ΔΨm. . Potential mechanism for the involvement of mitoK ATP in the proliferation of hPASMCs under hypoxic conditions. The mitochondrial inner membrane is polarized, with a negative matrix side due to a H + gradient generated by respiratory enzyme complexes. ATP is generated from ADP by ATP synthase and the energy is stored as the ΔΨm. MitoK ATP , which may be inhibited by ATP, mediates K + influx along the ΔΨm, causing a decrease in ΔΨm and regulation of ROS generation. Due to dysfunction of respiratory chain complexes, ROS levels are upregulated by two positive feedback loops: ROS/HIF/miR-210/ISCU and ATP/mitoK ATP/ ΔΨm. Along with regulation of HIF-1α, the aberrant ROS levels lead to the proliferation of hPASMCs under hypoxic conditions. MitoK ATP, mitochondrial ATP-sensitive potassium channel; hPASMCs, human pulmonary artery smooth muscle cells; ATP, adenoside triphosphate; ADP, adenoside diphosphate; ΔΨm, mitochondrial membrane potential; ROS, reactive oxygen species; HIF, hypoxia-inducible factor; miR, microRNA; ISCU, iron-sulfur cluster protein.
